Oligonucleotide synthesis is the process of building short sequences of nucleotides, the building blocks of DNA and RNA, using chemical techniques. Oligonucleotides are typically short, single-stranded pieces of nucleic acid that can be used for a variety of purposes, including as probes for detecting specific nucleic acid sequences, primers for PCR amplification, and as therapeutic agents in gene therapy.

There are a number of methods for synthesizing oligonucleotides, but the most commonly used method is solid-phase synthesis. In this technique, a solid support, typically a small bead, is used to anchor the first nucleotide in the sequence. The nucleotide is then modified with a chemical group that can be selectively removed to allow the addition of the next nucleotide in the sequence. This cycle is repeated until the desired sequence has been built up on the solid support. Finally, the oligonucleotide is cleaved from the solid support and purified.

Request Report Sample: https://www.alliedmarketresearch.com/request-sample/8721  

CAGR: 17.1%

• Current Market Size: USD 197.5 Million

• Forecast Growing Region: APAC

• Largest Market: North America

• Projection Time: 2021- 2031

• Base Year: 2021

Oligonucleotide Synthesis Market

The oligonucleotide synthesis market refers to the industry that produces and sells synthetic oligonucleotides, which are short strands of nucleic acid that are used in various applications, such as research, diagnostics, and therapeutics. The market has seen steady growth in recent years due to the increasing demand for oligonucleotides in molecular biology and biotechnology.

One major driver of the oligonucleotide synthesis market is the growing demand for oligonucleotides in research and diagnostic applications. Oligonucleotides are used as probes for detecting specific nucleic acid sequences, as primers for PCR amplification, and as tools for studying gene expression and regulation.

Procure Complete Report (243 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/2df86ceb32d9250a1d7ea0c2e1db6897

Another major driver of the market is the increasing use of oligonucleotides as therapeutic agents in gene therapy. Oligonucleotides can be designed to target specific genes or proteins, and they have shown promise in treating a variety of diseases, such as cancer and genetic disorders.

The market for oligonucleotide synthesis is highly competitive, with a number of major players, including Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies, and Eurofins Scientific. These companies offer a range of products and services, including custom oligonucleotide synthesis, oligonucleotide libraries, and oligonucleotide-based therapeutics.

For purchase inquiries: https://www.alliedmarketresearch.com/purchase-enquiry/8721

Related Reports –

Buttock Augmentation Market – https://www.alliedmarketresearch.com/buttocks-augmentation-market-A13341

Molecular Cytogenetics Markethttps://www.alliedmarketresearch.com/molecular-cytogenetics-market-A12298

Leave a comment

Your email address will not be published. Required fields are marked *